Rafael Schmerling retweeted
No Joke: Iran's regime was to host today a U.N. Human Rights Council event: “Situation of the women and girls in the Islamic Republic of Iran: latest breakthroughs.” Same regime that beats, blinds and rapes women who defend their rights. Event was just canceled, no reasons given.
Rafael Schmerling retweeted
Dasa e Amil se unem e criam a segunda maior rede de hospitais do país. A nova empresa já nasce com 25 hospitais, 30 centros oncológicos e 23 centros médicos. Combinada, a receita líquida estimada é da ordem de R$ 10,6 bilhões.
medicinasa.com.br/rede-ameri…
A DASA Oncologia, agora, é Americas! Somos uma das maiores redes de hospitais e clínicas de oncologia do Brasil.
1
32
Rafael Schmerling retweeted
Trigger warning. Don’t be silent when it comes to condemning rape. Speaking out and retweeting tells the victims and their loved ones we care about them. This could be your sister, daughter or partner. Their physical and psychological trauma is unimaginably painful - beyond words
Rafael Schmerling retweeted
The Clipper Airdrop has just went live!
All rewards are based on your on-chain activity.
Connect and check if you're eligible:
👉 clipperdex.net
Rafael Schmerling retweeted
A delivery driver who had almost finished crossing the road is shoved off his bike to make way for Joe Biden. This is what liberal democracy looks like. These people are better than you and don't you forget that.
Rafael Schmerling retweeted
MetaMask 🦊 is an amazing app for many reasons.
One reason I like especially is that even though it works just fine, the window object of the app is (almost) unusable!
If you're into Browser JavaScript security, come learn about what we call "scuttling" - by LavaMoat 🌋
Well..
‘Zoom fatigue’ is taxing the brain. Here's why that happens. nationalgeographic.com/scien… via @NatGeoScience
Rafael Schmerling retweeted
#Pembrolizumab + #Pazopanib: High incidence of LFTs increase (too toxic). @DrChoueiri @bporgbr @MOCBrasil #MOCnaASCO #ASCO17
Rafael Schmerling retweeted
Pembro should be the new SOC for bladder cancer. #ASCO17 #MOCnaASCO @bporgbr @MOCBrasil nitter.gq/drchoueiri/status/8717…
Rafael Schmerling retweeted
KEYNOTE-045 updated results. Even higher ORR due to more CR/PR over time. #ASCO17 #MOCnaASCO @bporgbr @MOCBrasil @OncoBellmunt @DrChoueiri
Rafael Schmerling retweeted
Nivolumab seem to be safe in #kidneycancer mRCC with brain mets, but caution w/ rapid progression. #ASCO2017 #MOCnaASCO @bporgbr @MOCBrasil
28% of patients with metastatic melanoma alive after 5y using dabrafenib/trametinib. #ASCO17 #MOCnaASCO @MOCBrasil
28% de paciente com melanoma vivos após 5 anos de dabrafenibe/trametinibe. Terapia alvo com plateau. #ASCO17 #MOCnaASCO @MOCBrasil
2 trials of Melanoma Brain Mets treated with IPI/NIVO. Itracranial response rate of 45-55%. Probable practice change #ASCO17 #MOCnaASCO
2 estudos com IPI/NIVO em metástases cerebrais de Melanoma: 45-55% de resposta no SNC!! Provável mudança da pratica. #ASCO17 #MOCnaASCO
Rafael Schmerling retweeted
#ASCO17 FASCO @PennCancer Lynn Schuchter discusses importance of communicating prognosis in pts with advanced #melanoma


























